Study of CM512 Injection in Patients With Perennial Allergic Rhinitis on Background Therapy | MicrobiomeTrials← Back to trialsNCT07890350
Study of CM512 Injection in Patients With Perennial Allergic Rhinitis on Background Therapy
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-10Est. Completion: 2028-06
Enrollment target: 200 participants Locations- Beijing Tongren Hospital, CMU, Beijing, Beijing Municipality, China
Other microbiome trials you might be interested in
Perennial Allergic Rhinitis (PAR)
The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in adult participants with perenni…
Huntington Beach, United StatesEst. completion Oct 22, 2026
Perennial Allergic Rhinitis
This Phase II Trial is Meant to Evaluate the Efficacy, and Safety of JYB1904 Injection in Patients With Perennial Allerg…
Multiple LocationsEst. completion Oct 2027